However, I found it very disturbing that the financial disclosures of these authors were not published nor made available to readers. Although Dr Ravindran and Dr Kennedy do not make specific recommendations regarding any particular antidepressant, they do endorse a pro-drug position. JAMA recently published an erratum relating to an article in which authors did not declare relevant links to pharmaceutical companies, despite the fact that a particular drug was not endorsed. 3 
Re: Effectiveness of Antidepressants
Dear Editor:
The February edition of The Canadian Journal of Psychiatry features a debate about the "real world" effectiveness of antidepressant medications. However, the debate overlooks a feature of major depression epidemiology that is critical to the topic in question.
In the debate, Dr Moncrieff cites evidence from a UK study reporting that depressed patients who are treated with antidepressants may be less rather than more likely to improve after discharge from hospital. 1 Similarly, in Canada it has been reported that people with major depression who take antidepressants have longer episodes than those who are untreated. 2 One explanation is that antidepressants may worsen the course of depression. 3 A competing explanation involves a methodological defect: confounding by episode duration.
One of the features of major depression epidemiology is that the rate of recovery from an episode is not constant. A constant rate of recovery (r) predicts that the proportion recovering by time (t) would be:
. This pattern has not been observed in epidemiologic studies. Instead, the rate of recovery declines with increasing episode duration.
Various strategies have been employed to describe the recovery pattern from depressive episodes in epidemiologic modelling. These include Markov "tunnels," 4 and Weibull 5 and lognormal 6 distributions. The implication is that recovery rates are high in the early weeks of an episode and that a sizable proportion of episodes resolve within a few weeks. On the other hand, patients presenting to psychiatrists typically have episodes that have already lasted many weeks and have lower rates of recovery. Treated patients can be expected to have longer episodes in real world populations because the effects of treatment are confounded with the effect of episode duration on prognosis. Confounding strong enough to cause an effect reversal is termed Simpson's Paradox in the epidemiologic literature.
The complexity of major depression epidemiology complicates the debate about antidepressant effectiveness. While observational data cannot easily be used to discount the potentially beneficial effects of antidepressants, it must also be acknowledged that some proportion of DSM-IV major depressive episodes occurring in the community are brief and probably self-limited. Many afflicted persons may indeed be entirely free of biological defects.
